129 related articles for article (PubMed ID: 26049033)
1. SIRT1 is a regulator of autophagy: Implications in gastric cancer progression and treatment.
Qiu G; Li X; Che X; Wei C; He S; Lu J; Jia Z; Pang K; Fan L
FEBS Lett; 2015 Jul; 589(16):2034-42. PubMed ID: 26049033
[TBL] [Abstract][Full Text] [Related]
2. EGCG Suppresses ERK5 Activation to Reverse Tobacco Smoke-Triggered Gastric Epithelial-Mesenchymal Transition in BALB/c Mice.
Lu L; Chen J; Tang H; Bai L; Lu C; Wang K; Li M; Yan Y; Tang L; Wu R; Ye Y; Jin L; Liang Z
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27447666
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Role of SIRT1-Autophagy Axis in Gastric Cancer.
Qiu G; Li X; Wei C; Che X; He S; Lu J; Wang S; Pang K; Fan L
Dis Markers; 2016; 2016():6869415. PubMed ID: 28070138
[No Abstract] [Full Text] [Related]
4. [Current views of the molecular mechanisms of gastric cancer progression].
Moskvina LV; Mal'kov PG
Arkh Patol; 2010; 72(4):58-61. PubMed ID: 21086643
[TBL] [Abstract][Full Text] [Related]
5. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells.
Russi S; Verma HK; Laurino S; Mazzone P; Storto G; Nardelli A; Zoppoli P; Calice G; La Rocca F; Sgambato A; Lucci V; Falco G; Ruggieri V
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370155
[TBL] [Abstract][Full Text] [Related]
6. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.
Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M
J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618
[TBL] [Abstract][Full Text] [Related]
7. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation.
Zhao Y; Guo Q; Chen J; Hu J; Wang S; Sun Y
Oncol Rep; 2014 Jan; 31(1):358-64. PubMed ID: 24247585
[TBL] [Abstract][Full Text] [Related]
8. SALL4, a novel marker for human gastric carcinogenesis and metastasis.
Zhang L; Xu Z; Xu X; Zhang B; Wu H; Wang M; Zhang X; Yang T; Cai J; Yan Y; Mao F; Zhu W; Shao Q; Qian H; Xu W
Oncogene; 2014 Nov; 33(48):5491-500. PubMed ID: 24276240
[TBL] [Abstract][Full Text] [Related]
9. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.
Cha EJ; Noh SJ; Kwon KS; Kim CY; Park BH; Park HS; Lee H; Chung MJ; Kang MJ; Lee DG; Moon WS; Jang KY
Clin Cancer Res; 2009 Jul; 15(13):4453-9. PubMed ID: 19509139
[TBL] [Abstract][Full Text] [Related]
10. Leptin and HER-2 are associated with gastric cancer progression and prognosis of patients.
Geng Y; Wang J; Wang R; Wang K; Xu Y; Song G; Wu C; Yin Y
Biomed Pharmacother; 2012 Sep; 66(6):419-24. PubMed ID: 22883999
[TBL] [Abstract][Full Text] [Related]
11. CD24 mediates gastric carcinogenesis and promotes gastric cancer progression via STAT3 activation.
Wang YC; Wang JL; Kong X; Sun TT; Chen HY; Hong J; Fang JY
Apoptosis; 2014 Apr; 19(4):643-56. PubMed ID: 24327257
[TBL] [Abstract][Full Text] [Related]
12. PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells.
Sun L; Li H; Chen J; Iwasaki Y; Kubota T; Matsuoka M; Shen A; Chen Q; Xu Y
J Cell Sci; 2013 Sep; 126(Pt 17):3939-47. PubMed ID: 23843607
[TBL] [Abstract][Full Text] [Related]
13. LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition.
Han Y; Ye J; Wu D; Wu P; Chen Z; Chen J; Gao S; Huang J
BMC Cancer; 2014 Dec; 14():932. PubMed ID: 25496320
[TBL] [Abstract][Full Text] [Related]
14. Akebia saponin PA induces autophagic and apoptotic cell death in AGS human gastric cancer cells.
Xu MY; Lee DH; Joo EJ; Son KH; Kim YS
Food Chem Toxicol; 2013 Sep; 59():703-8. PubMed ID: 23850994
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-κB/Cyclin D1 signaling.
Yang Q; Wang B; Gao W; Huang S; Liu Z; Li W; Jia J
Mol Cancer Res; 2013 Dec; 11(12):1497-507. PubMed ID: 24107295
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of autophagy in gastric carcinoma: Pathways to tumor progression and resistance to therapy.
Wen W; Ertas YN; Erdem A; Zhang Y
Cancer Lett; 2024 Jun; 591():216857. PubMed ID: 38583648
[TBL] [Abstract][Full Text] [Related]
17. The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer.
Okazaki M; Fushida S; Harada S; Tsukada T; Kinoshita J; Oyama K; Tajima H; Ninomiya I; Fujimura T; Ohta T
Cancer Lett; 2014 Dec; 355(1):46-53. PubMed ID: 25224569
[TBL] [Abstract][Full Text] [Related]
18. Use of KAI-1 as a prognostic factor in gastric carcinoma.
Ilhan O; Celik SY; Han U; Onal B
Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1369-72. PubMed ID: 19506480
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis.
Sentani K; Oue N; Naito Y; Sakamoto N; Anami K; Oo HZ; Uraoka N; Aoyagi K; Sasaki H; Yasui W
Carcinogenesis; 2012 May; 33(5):1081-8. PubMed ID: 22411957
[TBL] [Abstract][Full Text] [Related]
20. Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer.
Kim HP; Han SW; Song SH; Jeong EG; Lee MY; Hwang D; Im SA; Bang YJ; Kim TY
Oncogene; 2014 Jun; 33(25):3334-41. PubMed ID: 23873022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
